The Latest Cardiac and Vascular News
AV-101 is being developed to address cellular hyperproliferation and resistance to apoptosis in the pulmonary vasculature, which are key features of the pathophysiology of PAH PAH is an area of high unmet need, and currently approved therapies are limited by acting primarily through vasodilation These Phase 1 results show that […]
FDA Plans to Convene Advisory Committee Meeting SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the Company recently participated in a mid-cycle communication meeting with the U.S. Food & Drug Administration (FDA) and was informed that the Agency plans to convene an […]
LONDON, May 16, 2022 /PRNewswire/ — Tamer, the Middle-East’s leading healthcare distribution company, has agreed a 5-year deal to bring Huma’s market leading technology platform to power ‘hospitals at home’ with remote patient monitoring to the 34 million people living in the Kingdom of Saudi Arabia. The new health programme will begin with support for […]
PDUFA action date set for October 8, 2022 Company preparing for Q4 commercial launch, if approved BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient […]
The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent DUBLIN, May 13, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it received U.S. Food and Drug Administration (FDA) approval for the Onyx […]
Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions BOSTON, May 12, 2022 /PRNewswire/ — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced today that its Biofourmis Care solution has been selected by the American […]
WEST CHESTER, Pa., May 11, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce their participation and strong podium presence at the Charring Cross International Vascular Symposium. “Charring Cross” (CX), held annually in London, UK, is considered one of the premier global Vascular/Endovascular symposiums. Key Opinion Leaders from around the world assemble to […]
NAARDEN, Netherlands & MIAMI–(BUSINESS WIRE)–NewAmsterdam Pharma (NewAmsterdam), a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases, today announced the publication of a new meta-analysis in the European Heart Journal’s publication Cardiovascular Pharmacotherapy, discussing the effect of cholesteryl ester transfer protein (CETP) inhibitors on new-onset diabetes. […]
Cardiovascular study results to be presented by Prof. Ran Kornowski, Director of the Cardiology Center, Rabin Medical Center at the EuroPCR 2022 conference in May CAESAREA, Israel, May 10, 2022 /PRNewswire/ — Filterlex Medical Ltd., a cardiovascular medical device startup, announced today that it has completed its CAPTIS First-In-Human (FIH) study. Study results […]
Initial agreement includes comparison study of patient cardiac CT scans read by experts to those read by AI-based technology HUNTSVILLE, Ala., May 10, 2022 /PRNewswire/ — Artrya Ltd, creator of the AI-based cardiac software solution Artrya Salix, today announced its first U.S. clinical partnership with Alabama-based Huntsville Heart Center, Inc, a national leader […]
